Microparticles from apoptotic platelets promote resident macrophage differentiation

Cell Death and Disease

Volumn 2, Issue 9, 2011, Pages

  Vasina, E M ^a,b   Cauwenberghs, S ^a,c   Feijge, M A H ^b   Heemskerk, J W M ^b   Weber, C ^a,b,d,e   Koenen, R R ^a,b,d  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d UNIVERSITY OF MUNICH   (Germany)

^e Munich Heart Alliance   (Germany)

Author keywords

Apoptosis; Atherosclerosis; Inflammation; Phagocytes; Platelet microparticles; Resident macrophages

Indexed keywords

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; COGNITIVE DEFECT; CONTROLLED STUDY; EMBRYO; HIPPOCAMPAL CA1 REGION; MALE; MOUSE; NERVE SPROUTING; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; SYNAPSE; SYNAPTIC EFFICACY; ULTRASTRUCTURE; APOPTOSIS; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; ELECTRON MICROSCOPY; FEMALE; FLOW CYTOMETRY; HUMAN; MACROPHAGE; MEMBRANE MICROPARTICLE; METABOLISM; MONOCYTE; PHYSIOLOGY; THROMBOCYTE; TUMOR CELL LINE;

APOPTOSIS; BLOOD PLATELETS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HUMANS; MACROPHAGES; MALE; MICROSCOPY, ELECTRON; MONOCYTES;

EID: 80053396441     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2011.94     Document Type: Article

References (40)

1. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol 1967; 13: 269-288.
2. Berckmans RJ, Nieuwland R, Boing AN, Romijn FP, Hack CE, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001; 85: 639-646. (Pubitemid 32293699)
3. Italiano Jr JE, Mairuhu AT, Flaumenhaft R. Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol 2010; 17: 578-584.
4. Shantsila E, Kamphuisen PW, Lip GY. Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. J Thromb Haemost 2010; 8: 2358-2368.
5. Leroyer AS, Tedgui A, Boulanger CM. Role of microparticles in atherothrombosis. J Intern Med 2008; 263: 528-537. (Pubitemid 351533557)
6. Heemskerk JW, Kuijpers MJ, Munnix IC, Siljander PR. Platelet collagen receptors and coagulation. A characteristic platelet response as possible target for antithrombotic treatment. Trends Cardiovasc Med 2005; 15: 86-92. (Pubitemid 41021731)
7. Mason KD, Carpinelli MR, Fletcher JI, Collinge JE, Hilton AA, Ellis S et al. Programmed anuclear cell death delimits platelet life span. Cell 2007; 128: 1173-1186. (Pubitemid 46427871)
8. Grozovsky R, Hoffmeister KM, Falet H. Novel clearance mechanisms of platelets. Curr Opin Hematol 2010; 17: 585-589.
9. Jackson SP, Schoenwaelder SM. Procoagulant platelets: Are they necrotic? Blood 2010; 116: 2011-2018.
10. Cauwenberghs S, Feijge MA, Harper AG, Sage SO, Curvers J, Heemskerk JW. Shedding of procoagulant microparticles from unstimulated platelets by integrin-mediated destabilization of actin cytoskeleton. FEBS Lett 2006; 580: 5313-5320. (Pubitemid 44415813)
11. Elliott MR, Ravichandran KS. Clearance of apoptotic cells: implications in health and disease. J Cell Biol 2010; 189: 1059-1070.
12. Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV et al. Platelet microparticle membranes have 50-to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 2007; 97: 425-434. (Pubitemid 46437805)
13. Vasina E, Heemskerk JW, Weber C, Koenen RR. Platelets and platelet-derived microparticles in vascular inflammatory disease. Inflamm Allergy Drug Targets 2010; 9: 346-354.
14. Garcia BA, Smalley DM, Cho H, Shabanowitz J, Ley K, Hunt DF. The platelet microparticle proteome. J Proteome Res 2005; 4: 1516-1521. (Pubitemid 41464776)
15. Mause SF, Ritzel E, Liehn EA, Hristov M, Bidzhekov K, Muller-Newen G et al. Platelet microparticles enhance the vasoregenerative potential of angiogenic early outgrowth cells after vascular injury. Circulation 2010; 122: 495-506.
16. von Hundelshausen P, Koenen RR, Weber C. Platelet-mediated enhancement of leukocyte adhesion. Microcirculation 2009; 16: 84-96.
17. Sarabi A, Kramp BK, Drechsler M, Hackeng TM, Soehnlein O, Weber C et al. CXCL4L1 inhibits angiogenesis and induces undirected endothelial cell migration without affecting endothelial cell proliferation and monocyte recruitment. J Thromb Haemost 2011; 9: 209-219.
18. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5: 953-964. (Pubitemid 41746764)
19. Galt SW, Lindemann S, Medd D, Allen LL, Kraiss LW, Harris ES et al. Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and platelets. Circ Res 2001; 89: 509-516. (Pubitemid 34132645)
20. Jurasz P, Chung AW, Radomski A, Radomski MW. Nonremodeling properties of matrix metalloproteinases: the platelet connection. Circ Res 2002; 90: 1041-1043. (Pubitemid 34627901)
21. von Hundelshausen P, Weber KS, Huo Y, Proudfoot AE, Nelson PJ, Ley K et al. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 2001; 103: 1772-1777. (Pubitemid 32291415)
22. Weyrich AS, Elstad MR, McEver RP, McIntyre TM, Moore KL, Morrissey JH et al. Activated platelets signal chemokine synthesis by human monocytes. J. Clin. Invest. 1996; 97: 1525-1534. (Pubitemid 26097043)
23. Mause SF, von Hundelshausen P, Zernecke A, Koenen RR, Weber C. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 2005; 25: 1512-1518. (Pubitemid 40923377)
24. Gerdes N, Zhu L, Ersoy M, Hermansson A, Hjemdahl P, Hu H et al. Platelets regulate CD4+ T-cell differentiation via multiple chemokines in humans. Thromb Haemost 2011; 106: 353-362.
25. Tait JF, Smith C. Phosphatidylserine receptors: role of CD36 in binding of anionic phospholipid vesicles to monocytic cells. J Biol Chem 1999; 274: 3048-3054. (Pubitemid 29075393)
26. Freyssinet JM, Toti F. Formation of procoagulant microparticles and properties. Thromb Res 2010; 125 (Suppl 1): S46-S48.
27. Theilmeier G, Lenaerts T, Remacle C, Collen D, Vermylen J, Hoylaerts MF. Circulating activated platelets assist THP-1 monocytoid/endothelial cell interaction under shear stress. Blood 1999; 94: 2725-2734. (Pubitemid 29477301)
28. Barry OP, Pratico D, Savani RC, FitzGerald GA. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998; 102: 136-144. (Pubitemid 28323840)
29. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009; 27: 669-692.
30. Geissmann F, Gordon S, Hume DA, Mowat AM, Randolph GJ. Unravelling mononuclear phagocyte heterogeneity. Nat Rev Immunol 2010; 10: 453-460.
31. da Costa Martins PA, van Gils JM, Mol A, Hordijk PL, Zwaginga JJ. Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of beta1 and beta2 integrins. J Leukoc Biol 2006; 79: 499-507. (Pubitemid 44831227)
32. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 2007; 117: 185-194. (Pubitemid 46048465)
33. Koenen RR, Weber C. Therapeutic targeting of chemokine interactions in atherosclerosis. Nat Rev Drug Discov 2010; 9: 141-153.
34. Devitt A, Pierce S, Oldreive C, Shingler WH, Gregory CD. CD14-dependent clearance of apoptotic cells by human macrophages: the role of phosphatidylserine. Cell Death Differ 2003; 10: 371-382. (Pubitemid 36582375)
35. Feijge MA, van Pampus EC, Lacabaratz-Porret C, Hamulyak K, Levy-Toledano S, Enouf J et al. Inter-individual variability in Ca2+ signalling in platelets from healthy volunteers: effects of aspirin and relationship with expression of endomembrane Ca2+-ATPases. Br J Haematol 1998; 102: 850-859. (Pubitemid 28387072)
36. Hristov M, Gumbel D, Lutgens E, Zernecke A, Weber C. Soluble CD40 ligand impairs the function of peripheral blood angiogenic outgrowth cells and increases neointimal formation after arterial injury. Circulation 2010; 121: 315-324.
37. Fraemohs L, Koenen RR, Ostermann G, Heinemann B, Weber C. The functional interaction of the beta 2 integrin lymphocyte function-associated antigen-1 with junctional adhesion molecule-A is mediated by the I domain. J Immunol 2004; 173: 6259-6264. (Pubitemid 39487784)
38. Liehn EA, Piccinini AM, Koenen RR, Soehnlein O, Adage T, Fatu R et al. A new monocyte chemotactic protein-1/chemokine CC motif ligand-2 competitor limiting neointima formation and myocardial ischemia/reperfusion injury in mice. J Am Coll Cardiol 2010; 56: 1847-1857.
39. Groeneweg M, Vergouwe MN, Scheffer PG, Vermue HP, Sollewijn Gelpke MD, Sijbers AM et al. Modification of LDL with oxidized 1-palmitoyl-2- arachidonoylsn-glycero-3-phosphorylcholine (oxPAPC) results in a novel form of minimally modified LDL that modulates gene expression in macrophages. Biochim Biophys Acta 2008; 1781: 336-343.
40. Siljander P, Farndale RW, Feijge MA, Comfurius P, Kos S, Bevers EM et al. Platelet adhesion enhances the glycoprotein VI-dependent procoagulant response: Involvement of p38 MAP kinase and calpain. Arterioscler Thromb Vasc Biol 2001; 21: 618-627. (Pubitemid 32323397)